Bhagiradha Chemicals & Industries Limited Earnings Summary — Q1 FY2027

• Revenue from operations surged 57.5% YoY to ₹19,501.89 lakhs, reflecting strong demand in the crop protection segment.
• Consolidated Net Profit witnessed a massive turnaround, growing 235% YoY to ₹1,332.92 lakhs.
• Bheema Fine Chemicals, the wholly-owned subsidiary, contributed significantly to the consolidated topline and margin expansion.
• Operating performance improved drastically despite a substantial increase in raw material consumption, aided by a large inventory build-up of ₹5,032 lakhs.
• Finance costs nearly doubled YoY to ₹642.95 lakhs, highlighting the impact of increased debt for recent CAPEX projects.
• Profitability was supported by a more favorable tax expense ratio compared to the prior year's same quarter.
• The company continues to operate as a single-segment entity focused exclusively on Crop Protection Chemicals.

The company remains focused on ramping up its new manufacturing capacities and leveraging its specialized portfolio of 32 active ingredients to navigate the global agrochemical cycle.

Improving

A sharp recovery in both topline and bottom-line margins suggests the company is beginning to benefit from its heavy CAPEX phase and capacity expansion.

The successful integration and contribution from the subsidiary, coupled with a recovery in operating margins, position the company for a stronger fiscal year, provided global demand remains stable and inventory cycles normalize.